Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 14 Mar 2023
"You can't treat one of these conditions and ignore the others," says the author of the new review, explaining how obesity can affect the diagnosis and treatment of these heart conditions.
Read Full NewsThe newly approved generic product is expected to perform like other high-quality glatiramer acetate generics, with differences confined mainly to the manufacturer and device, not mechanism or dosing.
Catch up on any of the neurology news headlines you may have missed in December 2025, compiled into 1 place by the NeurologyLive® team.
A recent trial reveals semaglutide's potential for neurological improvement in stroke patients, despite no overall functional recovery benefits.
Nipocalimab Reduces SLE Disease Activity, Meeting JASMINE Study End Point
Pulmonology in 2025: Year in Review
Q4 2025 Recap: Pulmonology News and Updates
Switching Therapists for Psychotherapy Offers No Advantage in MDD
1.
Insurance Claim Denials for Preventive Care More Common in At-Risk Patients
2.
Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models
3.
A Lot Can Be Said About You by Including Yourself in Photos.
4.
Experts suggest Michelangelo depicted breast cancer in the Sistine Chapel fresco
5.
Study finds higher breast cancer rates in areas with more air pollution
1.
Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy
2.
Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide
3.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
4.
Managing Acute Respiratory Failure in Hematological Malignancies
5.
Exploring the Role of Fecal Leukocytes in Intestinal Health
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part II
2.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge